Taysha Gene Therapies, INC. (TSHA) — SC 13G/A Filings
All SC 13G/A filings from Taysha Gene Therapies, INC.. Browse 5 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (5)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Feb 14, 2024
-
TCG Crossover GP I Reports 0% Stake in Taysha Gene Therapies
— Feb 9, 2024 Risk: medium
TCG Crossover GP I, LLC, a Delaware-based entity, has filed an amended SC 13G/A for Taysha Gene Therapies, Inc. (NASDAQ: TSHA) as of December 31, 2023. This fil -
FMR LLC & Abigail Johnson Trim Taysha Gene Therapies Stake to 12.002%
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Taysha Gene Therapies, Inc. (TSHA) to 12.00
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX